Gemcitabine chemotherapy has been the standard for advanced pancreatic cancer for more than a *** oral fluoropyrimidines such as S-1 and capecitabine are other key *** plus erlotinib was the only combination therapy t...
详细信息
Gemcitabine chemotherapy has been the standard for advanced pancreatic cancer for more than a *** oral fluoropyrimidines such as S-1 and capecitabine are other key *** plus erlotinib was the only combination therapy that significantly prolonged survival,although the effect was *** or no improvement in survival with recent moleculartargeted drugs might be attributed to the very high incidence of K-ras gene mutation in pancreatic ***,the non-gemcitabine-based-regimen of FOLFIRINOX showed significantly greater overall survival compared with gemcitabine for the first *** biliary tract cancer,gemcitabine plus cisplatin combination chemotherapy has been proved to significantly prolong survival and will become the standard *** improvement in survival is expected by the addition of cetuximab.
暂无评论